Previous 10 | Next 10 |
SOHM, Inc. takes a step forward in establishing its manufacturing base and network in the USA CHINO HILLS, CA / ACCESSWIRE / April 27, 2021 / SOHM, Inc. (OTC PINK:SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs coveri...
CHINO HILLS, CA / ACCESSWIRE / February 26, 2019 / SOHM, Inc. (OTC PINK: SHMN), a generic Pharmaceutical , Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today that its Board of Directors has formally ap...
CHINO HILLS, CA / ACCESSWIRE / January 18, 2019 / SOHM, Inc. (OTC PINK: SHMN), a generic Pharmaceutical , Nutraceutical and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today some of developments with the company which i...
CHINO HILLS, CA / ACCESSWIRE / January 7, 2019 / SOHM, Inc. (OTC PINK: SHMN), a generic Pharmaceutical, Nutraceutical and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today the signing of a MASTER SUPPLY AGREEMENT with a ...
Chino Hills, CA, Aug. 09, 2018 (GLOBE NEWSWIRE) -- We are advised by SOHM, Inc. (PINKSHEETS: SHMN) that journalists and other readers should disregard the news release, "SOHM, Inc. Subsidiary Daiichi Sankyo Group Files Its Acute Myeloid Leukemia (AML) Treatment Quizartinib in the US; the FD...
Chino Hills, CA, Aug. 02, 2018 (GLOBE NEWSWIRE) -- SOHM, Inc. (PINKSHEETS: SHMN), a globally-known generic pharmaceutical manufacturer, is negotiating multiple purchase orders for a range of Pharmaceutical products. This potential purchase order comes from current customers that have execut...
Chino Hills, CA, Aug. 01, 2018 (GLOBE NEWSWIRE) -- SOHM, Inc. (PINKSHEETS: SHMN) a globally-known generic pharmaceutical manufacturer, is now active with the Nevada Secretary of State and is rigorously continuing to file all documents needed. All fees with the Nevada State have been submitt...
Chino Hills, CA, July 26, 2018 (GLOBE NEWSWIRE) -- SOHM, Inc. (PINKSHEETS: SHMN) a globally-known generic pharmaceutical manufacturer -- SOHM, Inc.’s Annual Financial for year ending 2016, 2017 and first qtr. which is ended on March 31, 2018: We are glad that we have now released all...
Chino Hills, CA, July 24, 2018 (GLOBE NEWSWIRE) -- SOHM, Inc. (PINKSHEETS: SHMN), a globally-known generic pharmaceutical manufacturer, would like to clarify certain information and facts as following. Our current Share Structure is as follows: Outstanding Shares 1,547,798,629 as of June 13...
SOHM, Inc. ( OTCPK:SHMN ): Q1 Revenue of $0.18M More news on: SOHM, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Sohm Inc Company Name:
SHMN Stock Symbol:
OTCMKTS Market:
2024-06-10 13:45:34 ET CAR T-cell therapy has seen significant growth and much promise, as it provides targeted and personalized treatment for patients with certain types of cancer, particularly those that have not responded to traditional forms of treatment such as chemotherapy or radiatio...
CHINO HILLS, CA / ACCESSWIRE / June 10, 2024 / SOHM, Inc. (OTC PINK:SHMN) (the "Company"), a pharmaceutical and upstart biotechnology company that manufactures and markets generic drugs covering numerous treatment categories, announced that preliminary data from a 3 rd party user resulted in AB...
SOHM (OTC: SHMN) , a leading generic pharmaceutical and upstart biotechnology company, today announced its ongoing work on ABBIE (A Binding Based Integrase Enzyme), a revolutionary retroviral integrase with a linked dCas9 DNA binding domain. The technology holds the potential to revolutionize gen...